Your next Drug Discovery Innovator
is CLOSING!
The story, the people and the name remain.
Feel free to contact any former collaborators of IntelDrug.

Reflecting on an Unforgettable Journey with IntelDrug 🚀

As we approach the end of 2024, it’s time for a different kind of announcement.

This year has been nothing short of remarkable. IntelDrug, the venture I launched with passion and a vision, has exceeded my expectations in so many ways. With more clients than ever before, from across the globe, IntelDrug achieved the impact I had hoped for—and then some. Together, we've explored new territories in drug design and AI, metabolism, longevity and others, forging strong bonds, meeting new people, and creating something truly special.

However, as with all journeys, some chapters must close to make way for new ones. Today, I’m announcing the closing of IntelDrug. While this decision wasn’t taken lightly, I am excited for what’s to come. This isn’t a goodbye; it’s a transition. I’m not disappearing, and you’ll be hearing from me soon about the next step in this journey.

I want to extend my heartfelt thanks to all the clients, partners, and friends who have been part of IntelDrug’s story. Your trust and collaboration have been invaluable, and I’m proud of what we’ve accomplished together.

As we wrap up IntelDrug, I’m filled with gratitude and optimism. Stay tuned for what comes next—it’s going to be exciting.
Wishing you all continued success and growth. Here’s to new beginnings and the endless possibilities ahead! 🌟

IntelDrug was a Swiss-based consulting firm that provided expert advisory services in 2022-2024.

Operating internationally, IntelDrug has partnered with you.
A start-up, mid-size, or large biotech or pharma company to start, improve and accelerate your Drug Discovery program.

ALL BELOW IS HISTORY.

Current drug discovery and development programs are becoming increasingly complex and multidisciplinary.

Biotechs look for the best setup right from the start. Pharma seeks to accelerate early drug development.

IntelDrug knows where to start and how to finish.